The aim of this article is to provide an overview of the nonavalent HPV vaccine, the rationale for its use, and the updated dose scheduling requirements for HPV vaccine.

This article provides a framework for interpreting paired Ross River virus and Barmah Forest virus serology results in an environment where numerical antibody titres are not routinely provided.